Login to Your Account



Other News To Note


Friday, July 8, 2011
Inovio Biomedical Corp., of Blue Bell, Pa., expanded its license agreement with the University of Pennsylvania, adding exclusive worldwide licenses for technology and intellectual property for DNA vaccines against pandemic influenza, Chikungunya and foot-and-mouth disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription